Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’ Farxiga shows CV benefit in diabetes patients

pharmatimesMarch 19, 2019

Tag: AstraZeneca , Farxiga , Dapagliflozin

PharmaSources Customer Service